{
  "referenceData":{"studyOID":"cdisc.com/CDISCPILOT01","metaDataVersionOID":"MDV.MSGv2.0.SDTMIG.3.3.SDTM.1.7","itemGroupData": {"IG.TS":{"records":51,"name":"TS","label":"Trial Summary","items":[{"OID": "IT.TS.STUDYID", "name":"STUDYID", "label":"Study Identifier", "type":"string", "length":12},{"OID": "IT.TS.DOMAIN", "name":"DOMAIN", "label":"Domain Abbreviation", "type":"string", "length":2},{"OID": "IT.TS.TSSEQ", "name":"TSSEQ", "label":"Sequence Number", "type":"integer"},{"OID": "IT.TS.TSGRPID", "name":"TSGRPID", "label":"Group ID", "type":"string", "length":200},{"OID": "IT.TS.TSPARMCD", "name":"TSPARMCD", "label":"Trial Summary Parameter Short Name", "type":"string", "length":8},{"OID": "IT.TS.TSPARM", "name":"TSPARM", "label":"Trial Summary Parameter", "type":"string", "length":40},{"OID": "IT.TS.TSVAL", "name":"TSVAL", "label":"Parameter Value", "type":"string", "length":200},{"OID": "IT.TS.TSVALNF", "name":"TSVALNF", "label":"Parameter Null Flavor", "type":"string", "length":4},{"OID": "IT.TS.TSVALCD", "name":"TSVALCD", "label":"Parameter Value Code", "type":"string", "length":200},{"OID": "IT.TS.TSVCDREF", "name":"TSVCDREF", "label":"Name of the Reference Terminology", "type":"string", "length":200},{"OID": "IT.TS.TSVCDVER", "name":"TSVCDVER", "label":"Version of the Reference Terminology", "type":"string", "length":200}],"itemData": [
["CDISCPILOT01","TS",1,null,"ACTSUB","Actual Number of Subjects","18",null,null,null,null],
["CDISCPILOT01","TS",1,null,"ADAPT","Adaptive Design","N",null,"C49487","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"ADDON","Added on to Existing Treatments","N",null,"C49487","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"AGEMAX","Planned Maximum Age of Subjects",null,"PINF",null,null,null],
["CDISCPILOT01","TS",1,null,"AGEMIN","Planned Minimum Age of Subjects","P50Y",null,null,"ISO 8601",null],
["CDISCPILOT01","TS",1,"CUTOFF","DCUTDESC","Data Cutoff Description","DATABASE LOCK",null,null,null,null],
["CDISCPILOT01","TS",1,"CUTOFF","DCUTDTC","Data Cutoff Date","2015-03-31",null,null,"ISO 8601",null],
["CDISCPILOT01","TS",1,"PLACEBO","DOSE","Dose per Administration","0",null,null,null,null],
["CDISCPILOT01","TS",2,"LOW-DOSE","DOSE","Dose per Administration","54",null,null,null,null],
["CDISCPILOT01","TS",3,"HIGH-DOSE","DOSE","Dose per Administration","54",null,null,null,null],
["CDISCPILOT01","TS",4,"HIGH-DOSE","DOSE","Dose per Administration","81",null,null,null,null],
["CDISCPILOT01","TS",1,null,"DOSFRM","Dose Form","INJECTION",null,"C42946","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"DOSFRQ","Dosing Frequency","QD",null,"C25473","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"DOSU","Dose Units","mg",null,"C28253","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"FCNTRY","Planned Country of Investigational Sites","USA",null,"USA","ISO 3166-1 alpha-3",null],
["CDISCPILOT01","TS",1,null,"HLTSUBJI","Healthy Subject Indicator","N",null,"C49487","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"INDIC","Trial Disease/Condition Indication","Alzheimer's Disease (Disorder)",null,"26929004","SNOMED","2019-03-01"],
["CDISCPILOT01","TS",1,null,"INTMODEL","Intervention Model","PARALLEL",null,"C82639","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"INTTYPE","Intervention Type","DRUG",null,"C1909","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"LENGTH","Trial Length","P28W",null,null,"ISO 8601",null],
["CDISCPILOT01","TS",1,null,"NARMS","Planned Number of Arms","3",null,null,null,null],
["CDISCPILOT01","TS",1,"EFFICACY","OBJPRIM","Trial Primary Objective","To document the efficacy profile of Zanomaline.",null,null,null,null],
["CDISCPILOT01","TS",2,"SAFETY","OBJPRIM","Trial Primary Objective","To document the safety profile of Zanomaline.",null,null,null,null],
["CDISCPILOT01","TS",1,"EFFICACY","OUTMSPRI","Primary Outcome Measure","To assess the dose-dependent improvement in subject depression. Improved scores on the Patient Health Questionnaire(PHQ-9) and the Hamilton Depression Rating Scale(HAMD 17) will indicate improvements.",null,null,null,null],
["CDISCPILOT01","TS",2,"EFFICACY","OUTMSPRI","Primary Outcome Measure","To assess the dose-dependent improvements in satisfaction with subjects' lives as a whole. Improved scores on the Satisfaction With Life Survery (SWLS) will indicate improvements.",null,null,null,null],
["CDISCPILOT01","TS",3,"EFFICACY","OUTMSPRI","Primary Outcome Measure","To assess the dose-dependent improvements in subject memory and learning. Improved scores on the Auditory Verbal Learning Test (AVLT-REY) will indicate improvements.",null,null,null,null],
["CDISCPILOT01","TS",4,"SAFETY","OUTMSPRI","Primary Outcome Measure","Type, frequency, and severity of laboratory abnormalities",null,null,null,null],
["CDISCPILOT01","TS",5,"SAFETY","OUTMSPRI","Primary Outcome Measure","Type, frequency, and severity of adverse events (AEs)",null,null,null,null],
["CDISCPILOT01","TS",1,null,"PCLAS","Pharmacologic Class","Acetylcholine Release Inhibitor",null,"N0000175771","MED-RT",null],
["CDISCPILOT01","TS",1,null,"PLANSUB","Planned Number of Subjects","20",null,null,null,null],
["CDISCPILOT01","TS",1,null,"RANDOM","Trial is Randomized","Y",null,"C49488","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"RANDQT","Randomization Quotient","0.67",null,null,null,null],
["CDISCPILOT01","TS",1,null,"REGID","Registry Identifier","NCT00000000",null,"NCT00000000","clinicaltrials.gov",null],
["CDISCPILOT01","TS",1,null,"ROUTE","Route of Administration","SUBCUTANEOUS",null,"C38299","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"SDTIGVER","SDTM IG Version","3.3",null,null,null,null],
["CDISCPILOT01","TS",1,null,"SDTMVER","SDTM Version","1.7",null,null,null,null],
["CDISCPILOT01","TS",1,null,"SENDTC","Study End Date","2014-11-01",null,null,"ISO 8601",null],
["CDISCPILOT01","TS",1,null,"SEXPOP","Sex of Participants","BOTH",null,"C49636","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"SPONSOR","Clinical Study Sponsor","SDTM Metadata Submission Guidelines Team",null,null,null,null],
["CDISCPILOT01","TS",1,null,"SSTDTC","Study Start Date","2012-10-06",null,null,"ISO 8601",null],
["CDISCPILOT01","TS",1,null,"STOPRULE","Study Stop Rules","NONE",null,null,null,null],
["CDISCPILOT01","TS",1,null,"STYPE","Study Type","INTERVENTIONAL",null,"C98388","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"TBLIND","Trial Blinding Schema","DOUBLE BLIND",null,"C15228","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"TCNTRL","Control Type","PLACEBO",null,"C49648","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"TDIGRP","Diagnosis Group","Patients with Probable Mild to Moderate Alzheimers Disease",null,null,null,null],
["CDISCPILOT01","TS",1,null,"TINDTP","Trial Intent Type","TREATMENT",null,"C49656","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"TITLE","Trial Title","Safety and Efficacy of Zanomaline in Patients with Mild to Moderate Alzheimers Disease.",null,null,null,null],
["CDISCPILOT01","TS",1,null,"TPHASE","Trial Phase Classification","PHASE II TRIAL",null,"C15601","CDISC","2020-03-27"],
["CDISCPILOT01","TS",1,null,"TRT","Investigational Therapy or Treatment","Zanomaline",null,"0XXX0X00XX","UNII",null],
["CDISCPILOT01","TS",1,null,"TTYPE","Trial Type","SAFETY",null,"C49667","CDISC","2020-03-27"],
["CDISCPILOT01","TS",2,null,"TTYPE","Trial Type","EFFICACY",null,"C49666","CDISC","2020-03-27"]
]}}}
}